Skip to main content

Adaptive Biotechnologies Corporation (ADPT)

NASDAQ: ADPT · IEX Real-Time Price · USD
4.90
-0.43 (-8.07%)
At close: Dec 29, 2023, 4:00 PM
4.91
+0.01 (0.20%)
After-hours: Dec 29, 2023, 7:33 PM EST

Adaptive Biotechnologies Market Cap

Adaptive Biotechnologies has a market cap or net worth of $709.39 million as of December 29, 2023. Its market cap has decreased by -38.38% in one year.

Market Cap
709.39M
Enterprise Value
566.56M
1-Year Change
-38.38%
Ranking
#2730
Category
Small-Cap
Stock Price
$4.90

Market Cap Chart

Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.88B to $709.39M, a decrease of -85.45%. That is a compound annual growth rate of -34.78%.

History

DateMarket Cap% Change
Dec 29, 2023709.40M
-8.06%
Dec 28, 2023771.60M
4.30%
Dec 27, 2023739.80M
1.19%
Dec 26, 2023731.10M
2.02%
Dec 22, 2023716.60M
-1.59%
Dec 21, 2023728.20M
6.12%
Dec 20, 2023686.20M
-6.33%
Dec 19, 2023732.60M
7.44%
Dec 18, 2023681.90M
-3.28%
Dec 15, 2023705.00M
-5.99%
Dec 14, 2023749.90M
4.43%
Dec 13, 2023718.10M
13.25%
Dec 12, 2023634.10M
-4.57%
Dec 11, 2023664.50M
-2.55%
Dec 8, 2023681.90M
1.08%
Dec 7, 2023674.60M
0.85%
Dec 6, 2023668.90M
4.53%
Dec 5, 2023639.90M
-7.14%
Dec 4, 2023689.10M
1.28%
Dec 1, 2023680.40M
7.30%
Nov 30, 2023634.10M
-5.20%
Nov 29, 2023668.90M
5.72%
Nov 28, 2023632.70M
0.93%
Nov 27, 2023626.90M
-0.92%
Nov 24, 2023632.70M
2.83%
View and export this data all the way back to 2019. Start Free Trial.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
BioLife Solutions 732.02M
Zymeworks 727.32M
Acelyrin 726.15M
Valneva SE 719.47M
OmniAb 717.15M
PureTech Health 703.07M
Fusion Pharmaceuticals 695.82M
Edgewise Therapeutics 694.27M
Market Cap Rankings